Advisory Services Network LLC lessened its stake in shares of McKesson Co. (NYSE:MCK - Free Report) by 6.6% during the fourth quarter, according to its most recent filing with the Securities & Exchange Commission. The firm owned 13,324 shares of the company's stock after selling 942 shares during the period. Advisory Services Network LLC's holdings in McKesson were worth $7,594,000 at the end of the most recent reporting period.
A number of other large investors have also bought and sold shares of the stock. Millstone Evans Group LLC purchased a new stake in shares of McKesson in the fourth quarter worth approximately $28,000. Synergy Asset Management LLC purchased a new stake in McKesson in the 4th quarter valued at $32,000. Crews Bank & Trust purchased a new position in McKesson during the 4th quarter worth $33,000. Atala Financial Inc bought a new stake in shares of McKesson in the 4th quarter worth $34,000. Finally, Graney & King LLC purchased a new stake in shares of McKesson in the fourth quarter valued at about $38,000. 85.07% of the stock is currently owned by institutional investors and hedge funds.
McKesson Stock Down 0.1 %
NYSE MCK traded down $0.57 on Monday, reaching $688.79. The company had a trading volume of 289,870 shares, compared to its average volume of 922,956. The stock has a market capitalization of $86.32 billion, a PE ratio of 31.54, a price-to-earnings-growth ratio of 1.29 and a beta of 0.49. McKesson Co. has a 12 month low of $464.42 and a 12 month high of $728.32. The firm's 50 day moving average price is $642.70 and its 200 day moving average price is $593.86.
McKesson (NYSE:MCK - Get Free Report) last released its quarterly earnings data on Wednesday, February 5th. The company reported $8.03 EPS for the quarter, missing the consensus estimate of $8.60 by ($0.57). McKesson had a net margin of 0.82% and a negative return on equity of 181.26%. On average, research analysts expect that McKesson Co. will post 32.77 EPS for the current year.
McKesson Announces Dividend
The firm also recently disclosed a quarterly dividend, which was paid on Tuesday, April 1st. Investors of record on Monday, March 3rd were issued a dividend of $0.71 per share. This represents a $2.84 annualized dividend and a yield of 0.41%. The ex-dividend date was Monday, March 3rd. McKesson's payout ratio is 13.00%.
Analyst Upgrades and Downgrades
Several equities analysts have recently issued reports on MCK shares. Citigroup reduced their target price on McKesson from $713.00 to $677.00 and set a "buy" rating for the company in a report on Friday, January 10th. StockNews.com downgraded shares of McKesson from a "strong-buy" rating to a "buy" rating in a report on Friday, February 14th. Wells Fargo & Company lifted their price objective on shares of McKesson from $641.00 to $691.00 and gave the stock an "equal weight" rating in a research report on Friday, March 14th. Mizuho increased their target price on shares of McKesson from $630.00 to $690.00 and gave the company a "neutral" rating in a research report on Thursday, April 3rd. Finally, Bank of America upped their price objective on McKesson from $665.00 to $755.00 and gave the company a "buy" rating in a research note on Friday. Three analysts have rated the stock with a hold rating, thirteen have assigned a buy rating and one has assigned a strong buy rating to the stock. According to MarketBeat.com, the stock presently has a consensus rating of "Moderate Buy" and a consensus price target of $668.50.
Read Our Latest Report on McKesson
Insider Transactions at McKesson
In related news, EVP Leann B. Smith sold 188 shares of the firm's stock in a transaction on Wednesday, February 12th. The shares were sold at an average price of $609.59, for a total transaction of $114,602.92. Following the completion of the transaction, the executive vice president now owns 1,051 shares of the company's stock, valued at $640,679.09. This trade represents a 15.17 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available at this hyperlink. Also, CEO Brian S. Tyler sold 8,961 shares of the business's stock in a transaction that occurred on Friday, February 14th. The shares were sold at an average price of $600.66, for a total value of $5,382,514.26. Following the completion of the transaction, the chief executive officer now directly owns 69,625 shares of the company's stock, valued at $41,820,952.50. The trade was a 11.40 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last ninety days, insiders sold 18,110 shares of company stock worth $10,855,706. Company insiders own 0.11% of the company's stock.
McKesson Company Profile
(
Free Report)
McKesson Corporation provides healthcare services in the United States and internationally. It operates through four segments: U.S. Pharmaceutical, Prescription Technology Solutions (RxTS), Medical-Surgical Solutions, and International. The U.S. Pharmaceutical segment distributes branded, generic, specialty, biosimilar and over-the-counter pharmaceutical drugs, and other healthcare-related products.
Featured Stories

Before you consider McKesson, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and McKesson wasn't on the list.
While McKesson currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Discover the 10 Best High-Yield Dividend Stocks for 2025 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.